Air Methods (AIRM) - FREE Research Report

Todd Aaron D who is Ceo at Air Methods sold 5,000 shares at $56.31 on Dec. 4, 2013. Following this transaction, the Ceo owned 82,371 shares meaning that the stake was reduced by 5.72% with the 5,000-share transaction.

The shares most recently traded at $55.23, down $1.08, or 1.96% since the insider transaction. Historical insider transactions for Air Methods go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 262,500

The average volume for Air Methods has been 339,800 shares per day over the past 30 days. Air Methods has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are up 50.34% year-to-date as of the close of trading on Wednesday.

Air Methods Corporation, together with its subsidiaries, provides air medical emergency transport services and systems in the United States. The company operates in two segments, Air Medical Services (AMS) and United Rotorcraft (UR). The company has a P/E ratio of 30.8. Currently there are 5 analysts that rate Air Methods a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AIRM - FREE

TheStreet Quant Ratings rates Air Methods as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Air Methods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Lockheed Martin, Raytheon, Activision Blizzard: 'Mad Money' Lightning Round

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)

Why the Permian Basin Isn't the Next Battle Ground for Corporate M&A

Why the Permian M&A Boom May Not End Well

How Apache May Be Quietly Funding Its Massive Alpine High Discovery